Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment

expresspharmaMay 20, 2021

Tag: Optimus , Molnupiravir , COVID-19 , DCGI

PharmaSources Customer Service